Product Information
EZETIMIBE-SIMVASTATIN 10-80 MG is a generic product labeled by Dr. Reddy's Laboratories Inc., priced at $0.3492 per EA under NDC 43598074590. Its NADAC has been published 368 times since Aug 7, 2019.
FDA first approved this application on Apr 26, 2017. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10; 80 mg/1; mg/1
Manufacturer
Dr. Reddy's Laboratories Inc.NDC
43598074590
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
Generic (ANDA)
FDA Application
ANDA200909FDA Approved
4/26/2017
TE Code
AB
On Market Since
11/20/2018
Pharmacological Classes
Price Statistics
The NADAC for EZETIMIBE-SIMVASTATIN 10-80 MG has been published 368 times since Aug 7, 2019, and over the history we have for it it has declined 82.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3492 per EA |
|---|---|
| All-time high | $2.2841 (Jan 15, 2020) |
| All-time low | $0.3124 (Apr 17, 2024) |
| 52-week high | $0.4771 |
| 52-week low | $0.3492 |
| Median price | $0.5578 |
| Average price | $0.8580 |
| Largest weekly change | -61.3% (Mar 23, 2022) |
| Weeks tracked | 368 |
| Tracking since | Aug 7, 2019 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of EZETIMIBE-SIMVASTATIN 10-80 MG?
The current National Average Drug Acquisition Cost (NADAC) for EZETIMIBE-SIMVASTATIN 10-80 MG, manufactured by Dr. Reddy's Laboratories Inc., is $0.3492 per EA (NDC 43598074590), effective Aug 19, 2026.
How has the price of EZETIMIBE-SIMVASTATIN 10-80 MG changed over time?
Over the history we have for it, the NADAC for EZETIMIBE-SIMVASTATIN 10-80 MG has declined 82.5%. It has been tracked across 368 weekly CMS publications since Aug 7, 2019.
What are the highest and lowest recorded NADAC prices for EZETIMIBE-SIMVASTATIN 10-80 MG?
Since Aug 7, 2019, the NADAC for EZETIMIBE-SIMVASTATIN 10-80 MG has ranged from a low of $0.3124 (Apr 17, 2024) to a high of $2.2841 (Jan 15, 2020), with a median of $0.5578 per EA.
Are there cheaper alternatives to EZETIMIBE-SIMVASTATIN 10-80 MG?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-80 MG, is $0.3277 per EA — about 6% below EZETIMIBE-SIMVASTATIN 10-80 MG.
Who manufactures EZETIMIBE-SIMVASTATIN 10-80 MG?
EZETIMIBE-SIMVASTATIN 10-80 MG (NDC 43598074590) is labeled by Dr. Reddy's Laboratories Inc., and CMS classifies it as a generic product.